AddLife AB logo

ALIF B - AddLife AB Share Price

SEK143.22 0.1  0.1%

Last Trade - 9:14am

Mid Cap
Market Cap £1.40bn
Enterprise Value £1.48bn
Revenue £358.2m
Position in Universe 242nd / 1772
Unlock ALIF B Revenue
Relative Strength (%)
1m +2.27%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -7.08%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
1,057 1,562 1,486 2,333 2,482 3,479 2,842 3,003 +26.9%
+3.1 -20.9 +8.4 +28.8 +9.5 -1.7
Balance Sheet
FINANCIAL BRIEF: : For the six months ended 30 June 2020, AddLife AB revenues increased 36% to SEK2.3B. Net income increased from SEK66M to SEK173M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Research and development decrease of 8% to SEK11M (expense). Basic Earnings per Share excluding Extraordinary Items increased from SEK0.61 to SEK1.55.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for ALIF B
Graphical History


ALIF B Revenue Unlock ALIF B Revenue

Net Income

ALIF B Net Income Unlock ALIF B Revenue

Normalised EPS

ALIF B Normalised EPS Unlock ALIF B Revenue

PE Ratio Range

ALIF B PE Ratio Range Unlock ALIF B Revenue

Dividend Yield Range

ALIF B Dividend Yield Range Unlock ALIF B Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
ALIF B EPS Forecasts Unlock ALIF B Revenue
Profile Summary

AddLife AB is a Sweden-based company, which is primarily involved in the healthcare industry. The Company markets and sells instruments, equipment, consumables and related services mainly to the healthcare sector. The Company operates through two segments: The LabTech segment is engaged in the sales of laboratory equipment, analytical instruments and reagents, that are used for diagnostics or biomedical research; The MedTech segment offers various medical device equipment, consumables, instruments and devices, primarily to hospitals. The Company operates through number of subsidiaries, such as BergmanLabora AB, BioNordica group, Holm & Halby A/S, Immuno Diagnostic Oy, LabRobot Products AB, Triolab-group, Active Care Sverup AB, Fenno Medical Oy, Mediplast AB, among others.

Last Annual December 31st, 2019
Last Interim June 30th, 2020
Public Since March 16, 2015
No. of Shareholders: 4,431
No. of Employees: 985
Sector Healthcare
Industry Biotechnology & Medical Research
Exchange OMX Nordic Exchange Stockholm
Shares in Issue 112,124,208
Free Float (0.0%)
Eligible for
ALIF B Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for ALIF B
Upcoming Events for ALIF B
Frequently Asked Questions for AddLife AB
What is the AddLife AB share price?

As of 9:14am, shares in AddLife AB are trading at SEK143.22, giving the company a market capitalisation of £1.40bn. This share price information is delayed by 15 minutes.

How has the AddLife AB share price performed this year?

Shares in AddLife AB are currently trading at SEK143.22 and the price has moved by 0.151k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the AddLife AB price has moved by 0.173k% over the past year.

What are the analyst and broker recommendations for AddLife AB?

Of the analysts with advisory recommendations for AddLife AB, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for AddLife AB is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will AddLife AB next release its financial results?

AddLife AB is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the AddLife AB dividend yield?

AddLife AB does not currently pay a dividend.

Does AddLife AB pay a dividend?

AddLife AB does not currently pay a dividend.

When does AddLife AB next pay dividends?

AddLife AB does not currently pay a dividend.

How do I buy AddLife AB shares?

To buy shares in AddLife AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of AddLife AB?

Shares in AddLife AB are currently trading at SEK143.22, giving the company a market capitalisation of £1.40bn.

Where are AddLife AB shares listed? Where are AddLife AB shares listed?

Here are the trading details for AddLife AB:

Country of listing: Sweden
Exchange: STO
Ticker Symbol: ALIF B
What kind of share is AddLife AB?

Based on an overall assessment of its quality, value and momentum, AddLife AB is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a AddLife AB share price forecast 2020?

Shares in AddLife AB are currently priced at SEK143.22. At that level they are trading at 57.23% discount to the analyst consensus target price of 0.00.

How can I tell whether the AddLife AB share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like AddLife AB. Over the past six months, the relative strength of its shares against the market has been 71.62%. At the current price of SEK143.22, shares in AddLife AB are trading at 41.72% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the AddLife AB PE Ratio?

The AddLife AB PE ratio based on its reported earnings over the past 12 months is 65.01. The shares are currently trading at SEK143.22.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of AddLife AB?

AddLife AB's management team is headed by:

Johan Sjo - CHM
Birgit Norinder - IND
Eva Nilsagard - IND
Hakan Roos - DRC
Stefan Hedelius - DRC
Kristina Willgard - PRE
Martin Almgren - CFO
Lars-Erik Rydell - OTH
Peter Simonsbacka - OTH
Andreas Gothberg - IND
Who are the major shareholders of AddLife AB?

Here are the top five shareholders of AddLife AB based on the size of their shareholding:

Fidelity Management & Research Company LLC Investment Advisor
Percentage owned: 10.42% (11.4m shares)
ODIN Forvaltning AS Investment Advisor
Percentage owned: 10.05% (11.0m shares)
Swedbank Robur Fonder AB Investment Advisor/Hedge Fund
Percentage owned: 7.2% (7.91m shares)
SEB Investment Management AB Investment Advisor
Percentage owned: 6.68% (7.34m shares)
Roos (Håkan) Individual Investor
Percentage owned: 6.45% (7.09m shares)
Similar to ALIF B
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.